Antonio Migliarese
2022
In 2022, Antonio Migliarese earned a total compensation of $1.7M as Chief Financial Officer at CytoDyn.
Compensation breakdown
| Option Awards | $1,302,000 |
|---|---|
| Salary | $411,567 |
| Stock Awards | $21,615 |
| Other | $12,347 |
| Total | $1,747,529 |
Migliarese received $1.3M in option awards, accounting for 75% of the total pay in 2022.
Migliarese also received $411.6K in salary, $21.6K in stock awards and $12.3K in other compensation.
Rankings
In 2022, Antonio Migliarese's compensation ranked 1,971st out of 5,760 executives tracked by ExecPay. In other words, Migliarese earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,971 out of 5,760 | 66th |
Division Manufacturing | 1,051 out of 3,136 | 67th |
Major group Chemicals And Allied Products | 448 out of 1,422 | 69th |
Industry group Drugs | 410 out of 1,323 | 69th |
Industry Pharmaceutical Preparations | 297 out of 969 | 69th |
Source: SEC filing on October 26, 2022.
Migliarese's colleagues
We found four more compensation records of executives who worked with Antonio Migliarese at CytoDyn in 2022.